Fig. 1 · Structure
Documents & Downloads
Telitacicept
(BLyS)/APRIL Inhibitor
Telitacicept is a fully human TACI-Fc fusion protein that functions as a dual inhibitor of B lymphocyte stimulator (BLyS) and APRIL (a proliferation-inducing ligand). This compound effectively suppresses B lymphocyte proliferation, making it a valuable tool for research in B-cell autoimmune diseases. Its specific mechanism can aid in the investigation of immune system dysregulation and the development of targeted therapeutic strategies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 2136630-26-5 |
| Applications | (BLyS)/APRIL Inhibitor |
| Molecular Weight | 75.36 kDa |
| Synonyms | RC18 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.